부산대학교 도서관

Blum KA; Emory University School of Medicine, Atlanta, Georgia.; Supko JG; Massachusetts General Hospital, Boston, Massachusetts.; Maris MB; Colorado Blood Cancer Institute, Denver, Colorado.; Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, Tennessee.; Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.; Younes A; Memorial Sloan Kettering Cancer Center, New York City, New York.; Bobba S; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Senderowicz AM; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Efuni S; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Rippley R; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Colak G; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Trojer P; Constellation Pharmaceuticals (a Morphosys Company), Boston, Massachusetts.; Abramson JS; Massachusetts General Hospital, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun

Stamou MI; Endocrine Division, Massachusetts General Hospital, Boston, MA.; Chen C; Department of Medicine, Stanford University School of Medicine,Palo Alto, CA.; Wander SA; Division of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Supko JG; Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA.; Juric D; Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA.; Bardia A; Division of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Wexler DJ; Harvard Medical School, Boston, MA.; Diabetes Unit, Massachusetts General Hospital, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Konstantinopoulos PA; Dana-Farber Cancer Institute, Boston, MA, USA. panagiotis_konstantinopoulos@dfci.harvard.edu.; Cheng SC; Dana-Farber Cancer Institute, Boston, MA, USA.; Supko JG; Massachusetts General Hospital, Boston, MA, USA.; Polak M; Dana-Farber Cancer Institute, Boston, MA, USA.; Wahner-Hendrickson AE; Mayo Clinic, Rochester, MN, USA.; Ivy SP; National Cancer Institute, Bethesda, MD, USA.; Bowes B; Dana-Farber Cancer Institute, Boston, MA, USA.; Sawyer H; Dana-Farber Cancer Institute, Boston, MA, USA.; Basada P; Dana-Farber Cancer Institute, Boston, MA, USA.; Hayes M; Dana-Farber Cancer Institute, Boston, MA, USA.; Curtis J; Dana-Farber Cancer Institute, Boston, MA, USA.; Horowitz N; Dana-Farber Cancer Institute, Boston, MA, USA.; Wright AA; Dana-Farber Cancer Institute, Boston, MA, USA.; Campos SM; Dana-Farber Cancer Institute, Boston, MA, USA.; Ivanova EV; Dana-Farber Cancer Institute, Boston, MA, USA.; Paweletz CP; Dana-Farber Cancer Institute, Boston, MA, USA.; Palakurthi S; Dana-Farber Cancer Institute, Boston, MA, USA.; Liu JF; Dana-Farber Cancer Institute, Boston, MA, USA.; D'Andrea AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Gokhale PC; Dana-Farber Cancer Institute, Boston, MA, USA.; Chowdhury D; Dana-Farber Cancer Institute, Boston, MA, USA.; Matulonis UA; Dana-Farber Cancer Institute, Boston, MA, USA.; Shapiro GI; Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Lopez BGC; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Kohale IN; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Du Z; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Korsunsky I; Center for Data Sciences, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Abdelmoula WM; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Dai Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Stopka SA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Gaglia G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Randall EC; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Regan MS; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Basu SS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Clark AR; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Marin BM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Mladek AC; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Burgenske DM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Agar JN; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.; Supko JG; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Grossman SA; Brain Cancer Program, Johns Hopkins Hospital, Baltimore, Maryland, USA.; Nabors LB; University of Alabama at Birmingham, Birmingham, Alabama, USA.; Raychaudhuri S; Center for Data Sciences, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ligon KL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Alexander B; Department of Radiation Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Santagata S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sarkaria J; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.; White FM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Agar NYR; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.; Blonquist TM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Stevenson KE; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Supko JG; Department of Medicine, Massachusetts General Hospital, Boston, MA.; Hunt SK; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cronholm SM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Koch V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Kay-Green S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Athale UH; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, ON, Canada.; Clavell LA; Division of Pediatric Oncology, San Jorge Children's Hospital, San Juan, Puerto Rico.; Cole PD; Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.; Harris MH; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Kelly KM; Department of Pediatric Oncology, Roswell Park Cancer Institute and Oishei Children's Hospital, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY.; Laverdiere C; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.; Leclerc JM; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.; Michon B; Division of Hematology-Oncology, Centre Hospitalier Universite de Quebec, Quebec City, Canada.; Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.; Schorin MA; Inova Fairfax Hospital for Children, Falls Church, VA.; Welch JJG; Division of Pediatric Hematology/Oncology, Hasbro Children's Hospital, Brown University Medical School, Providence, RI.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.; Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Clark SL; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Li T; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Goel S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Tayob N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Viscosi E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Abraham E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Juric D; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Mayer E; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Supko JG; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Tolaney SM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Bardia.Aditya@mgh.harvard.edu.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Walker SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Heppler LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Nelson EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Klitgaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Nicolais M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Kroll Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Xiang M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Yeh JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chaudhury M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Giaccone ZT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Freedman AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Supko JG; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Wu C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Frank DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Duska LR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: lduska@virginia.edu.; Krasner CN; Dana Farber Cancer Institute, Boston, MA, USA.; O'Malley DM; James Comprehensive Cancer Center and Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.; Hays JL; James Comprehensive Cancer Center and Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.; Modesitt SC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.; Mathews CA; Women and Infants Hospital, Providence, RI, USA.; Moore KN; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Thaker PH; Washington University School of Medicine, St. Louis, MO, USA.; Miller A; Roswell Park Comprehensive Center, Buffalo, NY, USA.; Purdy C; Roswell Park Comprehensive Center, Buffalo, NY, USA.; Zamboni WC; UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center of Nanotechnology Excellence, University of North Carolina, Chapel Hill, NC, USA.; Lucas AT; UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center of Nanotechnology Excellence, University of North Carolina, Chapel Hill, NC, USA.; Supko JG; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA 20114, USA.; Schilder RJ; Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadephia, PA, USA.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Tripathi A; University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.; Supko JG; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Gray KP; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Frontier Science Foundation, Boston, Massachusetts.; Melnick ZJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Taplin ME; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Choudhury AD; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pomerantz MM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Yu C; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sun Z; Beckman Research Institute, City of Hope, California.; Stanford University, Stanford, California.; Srinivas S; Stanford University, Stanford, California.; Kantoff PW; Memorial Sloan Kettering Cancer Center, New York, New York.; Sweeney CJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. lcharshman@gmail.com.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Do KT; Dana-Farber Cancer Institute, Boston, MA, USA. Khanh_Do@dfci.harvard.edu.; Center for Cancer Therapeutic Innovation, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue -DA2010, Boston, MA, 02215, USA. Khanh_Do@dfci.harvard.edu.; O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Hays JL; The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Supko JG; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Liu SV; Georgetown University Medical Center, Washington, DC, USA.; Beebe K; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Neckers L; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Smyth T; Astex Pharmaceuticals, Cambridge, UK.; Gannon C; Dana-Farber Cancer Institute, Boston, MA, USA.; Hedglin J; Dana-Farber Cancer Institute, Boston, MA, USA.; Muzikansky A; Massachusetts General Hospital Biostatistics Center, Boston, MA, USA.; Campos S; Dana-Farber Cancer Institute, Boston, MA, USA.; Lyons J; Astex Pharmaceuticals, Cambridge, UK.; Ivy P; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Shapiro GI; Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE